Partnering with MCTC
Barriers to Industry-sponsored Myositis Clinical Trials
- High cost to open investigator site
- Low actual recruitment rate of selected sites
- Fractionated sources of site characteristic and performance data
Advantages of partnering with MCTC
Optimal site selection
- Global directory of myositis investigators, sites, and patients
- Coordinated network of reliable site investigators with validated expertise in myositis clinical trials
- Access to consolidated information to enhance informed site selection
Enhanced trial recruitment
- Community of traditional research trial sites coupled to collaborating regional sites/partnersEthnic, racial and geographically diverse population
- Decreased competing overlap in recruitment amongst multiple trials and sites
- Buy-in from prominent leaders in myositis clinical research and patient groups from a broad cross-section of medical disciplines and geography
International myositis experts
- Consultation with MCTC’s multidisciplinary physician team
- Enhanced coordination amongst consortium members, including shared best practices
- Training and certification for investigators/clinical research team
Key stakeholders buy-in
- Integration of multiple stake-holders, including non-physician myositis experts, clinical research coordinators, patient advocacy groups, etc.
Benefits of Partnership
- We offer three different level of partnership, providing different levels of visibility, long-term impact, educational involvement and research grants.